Futurelife Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 08-12-2024
- Paid Up Capital ₹ 0.50 M
as on 08-12-2024
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2019
- Revenue 49.71%
(FY 2019)
- Profit -84.71%
(FY 2019)
- Ebitda -35.92%
(FY 2019)
- Net Worth 80.13%
(FY 2019)
- Total Assets 120.85%
(FY 2019)
About Futurelife Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Hardik Dodia and Yajushi Dodiya serve as directors at the Company.
- CIN/LLPIN
U24230GJ2013PTC077906
- Company No.
077906
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Dec 2013
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Futurelife Pharmaceuticals Private Limited offer?
Futurelife Pharmaceuticals Private Limited offers a wide range of products and services, including Herbal Juice, Aloe Vera Juice, Beauty Soap, Acne Soap, Ayurvedic & Herbal Health Supplement, Amla Juice.
Who are the key members and board of directors at Futurelife Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hardik Dodia  | Director | 16-Dec-2013 | Current |
| Yajushi Dodiya | Director | 16-Dec-2013 | Current |
Financial Performance of Futurelife Pharmaceuticals.
Futurelife Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 49.71% increase. The company also saw a substantial fall in profitability, with a 84.71% decrease in profit. The company's net worth Soared by an impressive increase of 80.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Futurelife Pharmaceuticals?
In 2019, Futurelife Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Futurelife Herbals Private LimitedActive 11 years 22 daysHardik Dodia and Yajushi Dodiya are mutual person
- Flamingo Consign Private LimitedActive 13 years 7 months
Hardik Dodia and Yajushi Dodiya are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Futurelife Pharmaceuticals?
Unlock and access historical data on people associated with Futurelife Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Futurelife Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Futurelife Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
